The goal of this activity is for learners to better understand the regional guidelines on hormone receptor (HR)-positive / human epidermal growth factor receptor 2 (HER2)-negative early breast cancer and how to apply them to their clinical practice when identifying patients who could benefit from oral anti-cancer therapies.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1000355
- Start Date: 2024-03-11 05:00:00
- End Date: 2024-03-11 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Lilly (Any division) - Amount: 131811.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest